Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Industry News

| More

New Zealand aids drug delivery research at IIT Bombay

Posted On: 2012-10-16 20:30:57

Drug delivery research in India will advance with help from New Zealand, with the gift of a highly advanced qNano system to Prof. Rinti Banerjee from the Department of Biosciences & Bioengineering at the Indian Institute of Technology (IIT) in Mumbai.

New Zealand nanotechnology company Izon Science gifted the instrument to accelerate advancement of research in the area of nanoparticles for drug delivery. The gift recognises the path-breaking technology platform and drug delivery mechanism award winning Prof. Rinti Banerjee has developed. The qNano provides the highly accurate information required to aid development of drug delivery systems that could deliver cancer drugs directly to the tumor.

The qNano system was presented to Prof. Banerjee by Hans van der Voorn, the Executive Chairman of Izon Science. The function held at IIT Bombay was attended by Hon Steven Joyce, New Zealand's Science and Innovation Minister, as part of his visit to India with a delegation of New Zealand education and aviation companies. Acting Director of IIT Bombay, Prof. R.K. Malik and Prof. N.S. Punekar, Head of Department of Biosciences & Bioengineering were also present at the occasion.

Prof. Banerjee is the winner of numerous awards for her work including most recently the prestigious National Award for Women Bio-scientists by the Department of Biotechnology, Government of India.

Her group works in the area of nanomedicine. Her group focuses on development of non-invasive carriers for delivery of drugs using specifically engineered nanoparticle technologies.

At present the technologies are being developed for therapy in cancers, respiratory diseases, ocular diseases and malnutrition. Several technologies developed by her group have been patented and have shown promising effects in in vivo animal models. Prof. Banerjee is keen to collaborate with industrial partners for further translation of these technologies.

Gavin Young, New Zealand's Trade Commissioner and Consul General in Mumbai says, "It's great to see a New Zealand company helping researchers in India at the forefront of new research frontiers. New Zealand's focus on science and innovation is something we share with India."

Izon Science's Hans van der Voorn says, "We're very pleased to be contributing to Prof. Banerjee's very important research work into controlled release drug delivery. This research could lead to the development of high value added products that could really make a difference to people's wellbeing worldwide, as well as to the Indian economy.

"This gift is a sign of our commitment to building business and research relationships in India. Half of our global sales already come from Asia and we see India as a very important market going forward."

Prof. Banerjee says, "I am thankful to Izon Science, New Zealand for presenting me with qNano which is a state-of-the art piece of equipment renowned for its precise measurements of nanoparticle sizes and concentrations. I am very excited that qNano will help us in accelerating our translational efforts in nanoparticle based drug delivery for affordable therapies in cancers and other diseases worldwide."

Targeted drug delivery offers enormous health benefits as smaller doses of drugs are delivered directly and achieve delivery of therapeutic levels of drugs over long periods of time without dose fluctuations. Targeted drug delivery also result in fewer side effects than pulse entry drug delivery. Targeted delivery of cancer drugs directly to the tumor is seen as a key application.

Prof. Banerjee is also interested in using drug loaded biological nanoparticles for respiratory, ophthalmic and transdermal delivery of drugs. The main objective is to design nanoparticles to reduce the systemic toxicity of the drugs and administer them through non-invasive, patient compliant routes.

"The qNano is a great way to enable researchers and students alike to do high quality bio and nanotechnology research and to be on the forefront of new research frontiers. Our instruments are extremely accurate and very affordable. One electron microscope is about the same price as 25 or 30 qNanos and our instruments are actually more accurate for particle research," says van der Voorn.

Izon Science's qNano and qViro instruments enable extremely precise measurement of nano and micro-particle samples by measuring the physical properties (size, concentration and surface charge) of individual particles as they pass through the unique size-tunable nanopores. The instruments are advancing research in a number of fields including drug delivery, hematology, biomedical diagnostics, and vaccine development.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

IBM and Red Hat Collaborate to Accelerate Hybrid Cloud Adoption with OpenStack
Elara Technologies Introduces a Un ique Offering for the Indian Real Estate Ecosystem for International Exposure
Tally Solutions joins hands with The Guild and CNBC Awaaz as Technology Partner and conducts its 'SME Futures' program in Hyderabad
Birlasoft Announces TruView CLM - a Salesforce Fullforce Solution for Media & Entertainment industry
Manipal CDC's new platform makes maiden investment in iGenetic Diagnostics
Tractors India Private Limited inks deal with RungePincockMinarco to deliver enterprise solutions for the Digital Mines of the Future
NASSCOM President Concludes Visit to Washington, DC
Quartz wins Arbitration Case against Jindal India Thermal Power Ltd
Suryoday Small Finance Bank Raises Around INR 160 Crores, Net-Worth Crosses INR 500 Crores
Despite Challenges Pharma Sector to Grow and Generate High Employment - Experts
AnandRathi Extends Support to Flexi Capital in Strategic Association
PUMA signs global sports icon and Indian Cricket Captain Virat Kohli as their Brand Ambassador
Apollo Munich Health Insurance wins Golden Peacock Award for Risk Management 2017
Zerodha's Client Base grows to 2.2 lakhs in 1 year
CarTrade raises US$55 million to drive growth in online automobile classifieds
SIDBI and LIC jointly signs agreements with 7 Venture Funds under SIDBI - LIC MOU
Angel Broking launches ARQ - A Wealth Management Engine for Retail Investors
Angel Broking steps up on Advanced Data Analytics to enhance customer experience
Angel Broking launches "Spotlight"- digital platform for employee appreciation
Ameyo on boards Schneider Electric's Ramesh Srinivasan as President Business Development
Muthoot Fincorp takes the Kabali fever farther, wider on ground
Shardul Amarchand Mangaldas & Co advises Privi Organics on Rs. 370 Crs PE Investment by FIH Mauritius Investments Ltd.
Angel Broking's Recruitment goes Digital
Customs policy for warehouses - All risk insurance: AnandRathi Insurance Brokers
Angel Broking launches #Customer Service on Facebook & Twitter
Motoziel and Edelweiss Bike Travel Announces Joint Venture
Bharti AXA Life Insurance launches "Bharti AXA Life Monthly Advantage"
Angel Broking goes for a nationwide "Digi-Pitch"
Ground Handlers Give Thumbs Up to Civil Aviation Policy; Non-Entitled Ground Handling Agencies Shown the Door
CapitalVia Global Research and Khadi Gramudhyog, Dept of MP join hands to host Corporate Khadi Mela
MySeniorDoctor.com Launches Electronic Medical Record facility
Drishti-soft Solutions receives Honourable Mention in Gartner Magic Quadrant for Contact Center Infrastructure, Worldwide
India PM Narendra Modi addresses the USIBC's 41st Leadership Summit in Washington, D.C.
Now India will 'Trade in 1 hour' : Angel Broking
Angel Broking goes beyond E-KYC; launches D-KYC
LANXESS raises guidance for 2016 after strong first quarter
Preparing Champions for Business of Sports Management
Shri Pralhad P Chhabria, Founder & Chairman of Finolex group passed away
Rays Power Infra forays into north India with Opex Model-Rays Solar Kart
Nandan Nilekani boards RailYatri.in with undisclosed amount of funding
Confederation of ATM Industry holds its First Annual Conference in Mumbai
vCommission invests in two new ventures - 'LetReach' & 'Spinsvilla'
LANXESS takes over Chemours' Clean and Disinfect specialities business
Gangavaram Port inaugurates "Water Distribution Program" for nearby villages
Modern, more efficient and safer - the aromatics network of LANXESS
IP-COM Rolls out AP355 Indoor High Capacity Access Point
India's Energy Minister, Piyush Goyal Discusses Opportunities in the Renewable Energy Sector with U.S. and Indian Industry
Pahal Financial Services Pvt Ltd announces resignation of Chairman
Waaree Energies announces the launch of its first Plug and Play solar Park "Sunbless"
Jabong launches international fashion brand Mexx exclusively in India


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017